Annales d'endocrinologie
Chapter 11: Treatment modalities
Abstract
Treatment modalities for primary hyperparathyroidism must take account of the expected benefits and risks of each treatment envisaged, before choosing the definitive option to be proposed to the patient. In this section, a Foreword puts in perspective the difficulties involved in choosing the criteria for a particular treatment method. Treatments are then considered one after the other: surgery, local destruction and medical management. This section does not consider therapeutic indications, which are dealt with in a section 9.
Source and rights
Published by Annales d'endocrinologie, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2025
- Applies to
- 🇫🇷 France
- Scope
- National
- Journal
- Annales d'endocrinologie
- PubMed
- 39818297
- Added to Prognia
- 22 July 2026
More in other
- The Canine Cognitive Dysfunction Syndrome Working Group guidelines for diagnosis and monitoring of canine cognitive dysfunction syndromeEuropean Respiratory Society · 2026
- Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2026)Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
